Mandate

Vinge advises Ambea on its acquisition of Aleris Care

October 16, 2018 Banking and Finance

Vinge has advised Ambea on its acquisition of Aleris’ care operations (“Aleris Care”) from Sirela Sweden AB, which is indirectly owned by Investor through Patricia Industries.

The purchase price amounted to SEK 2.6 billion on a debt free case free basis. Aleris Care is the leader in the private market for care services in Norway, the sixth largest private operator in Sweden and the largest private provider in the Denmark. Today, Ambea is the second largest player in the private market for care services in Sweden and the seventh largest in Norway. Following the acquisition, Ambea will be the largest care provider in the Nordic region with operations in Sweden, Norway and Denmark. The transaction is subject to regulatory approval by the relevant competition authorities and closing is expected to occur during the first quarter of 2019.
 
Vinge’s team consisted of partners Christina Kokko (M&A), Charlotte Levin (Public M&A and Capital Markets), Albert Wållgren (Banking and Finance) and Johan Karlsson (Competition) together with associates Johanna Wiberg, Martin Cronsioe and Karolina Cohrs (M&A), Linn Adelwald, Josefine Lanker and Josefine Larsson (Banking and Finance), Nicklas Thorgerzon, Fredrika Hjelmberg, Hayaat Ibrahim and Victor Berg (Commercial Agreements), Klara Secher (IP), Kristoffer Larson (Real Estate), Sara Strandberg and Lisa Ullman (Employment), Trine Osen Bergqvist, Xandra Ståhlberg and Sofia Landolsi (Competition), Hannes Pettersson (Corporate), Maria Schultzberg, Victor Ericsson and Henrik Wastenson (Tax) and VDR assistant Jessica Öijer. 

Selmer (Norway) and Accura (Denmark) has advised on the transaction’s Norwegian and Danish legal and tax aspects. 
 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025